Laboratory-Based SARS-CoV-2 Receptor Binding Domain Serologic Assays Perform with Equivalent Sensitivity and Specificity to Commercial FDA-EUA Approved Tests

During early phases of the SARS-CoV-2 epidemic, many research laboratories repurposed their efforts towards developing diagnostic testing that could aid public health surveillance while commercial and public diagnostic laboratories developed capacity and validated large scale testing methods. Simult...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehring, Mary, Pugh, Sierra, Dihle, Tina, Gallichotte, Emily, Nett, Terry, Weber, Eric, Mayo, Christie, Lynn, Lori, Ebel, Greg, Fosdick, Bailey K., VandeWoude, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860642/
https://www.ncbi.nlm.nih.gov/pubmed/36680146
http://dx.doi.org/10.3390/v15010106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860642/
https://www.ncbi.nlm.nih.gov/pubmed/36680146
http://dx.doi.org/10.3390/v15010106

Ejemplares similares